Hangzhou Tigermed Consulting Co., Ltd. (Tigermed) has issued a notice convening its 2025 Annual General Meeting (AGM) for 10:00 a.m. on 2 June 2026 at the company’s headquarters in Hangzhou, the People’s Republic of China.

Key matters up for shareholder approval include:

1. 2025 Results and Distribution • Adoption of the 2025 Annual Report, Board Report and Final Financial Report. • Approval of the 2025 profit-distribution plan.

2. Corporate Governance and Audit • Appointment of the external auditor for the 2026 financial year. • Establishment of an integrated credit facility with a bank. • Confirmation of remuneration and allowance standards, together with a formal remuneration management system for directors and senior management.

3. Capital Management • Special resolutions to amend the Articles of Association. • Renewal of a general mandate authorising the Board to issue H shares. • Renewal of a general mandate authorising the Board to repurchase H shares.

4. Board Composition (Cumulative Voting) Executive Directors—re-election of Dr. Ye Xiaoping, Ms. Cao Xiaochun and Mr. Wen Zengyu. Independent Non-executive Directors—re-election of Mr. Yuan Huagang and Ms. Liu Yuwen, plus the proposed appointment of Mr. Siu, Paul Yu Hay.

Shareholders recorded on the H-share register as of 2 June 2026 are entitled to attend and vote. The register will be closed from 28 May to 2 June 2026, and proxy forms must be lodged at Tricor Investor Services Limited at least 24 hours before the meeting. Voting will be conducted by poll, with ordinary resolutions requiring simple majority approval and special resolutions requiring at least a two-thirds majority. The cumulative voting method will apply to board elections.